Avience Biomedicals IPO GMP, ସଦସ୍ୟତା ଏବଂ ଆବଣ୍ଟନ ସ୍ଥିତି ଆଜି
Avience Biomedicals is a SME IPO with a price band of Rs 196.00 to Rs 208.00 that listed on 25 Jun 2026 at a listing gain of +90.00%. Track its full GMP history, subscription data and listing details here.
- IPO ପ୍ରାଇସ୍ ବ୍ୟାଣ୍ଡ
- ₹196.00 - ₹208.00
- ଲଟ୍ ଆକାର
- 600 ସେୟାର
- ବିଡିଂ ବନ୍ଦ
- 22 Jun 2026
- ଲିଷ୍ଟିଂ ତାରିଖ
- 25 Jun 2026
IPO ସୂଚନା ସମ୍ପୂର୍ଣ୍ଣ କରନ୍ତୁ
| IPO ଖୋଲିବା ତାରିଖ | 18 Jun 2026 |
|---|---|
| IPO ବନ୍ଦ ତାରିଖ | 22 Jun 2026 |
| IPO ପ୍ରାଇସ୍ ବ୍ୟାଣ୍ଡ | ₹196.00 - ₹208.00 |
| ଲଟ୍ ଆକାର | 600 ସେୟାର |
| ସାମ୍ପ୍ରତିକ GMP | ₹187.2 |
| ଆନୁମାନିକ ଲିଷ୍ଟିଂ ଲାଭ | +90.00% |
| ଇସ୍ୟୁ ଆକାର | - |
| ଫ୍ରେସ୍ ଇସ୍ୟୁ | - |
| ଇସ୍ୟୁ ପ୍ରକାର | ଏସଏମଇ |
| IPO ଲିଷ୍ଟିଂ | ଏନଏସଇ, ବିଏସଇ |
| ଖୁଚୁରା କୋଟା | ଟିବିଏ |
| ରେଜିଷ୍ଟ୍ରାର | ଟିବିଏ |
| ମୋଟାମୋଟି ସବସ୍କ୍ରିପସନ୍ | 43.79x |
| ସର୍ବନିମ୍ନ ନିବେଶ | ₹2,49,600 |
| DRHP ଡ୍ରାଫ୍ଟ ପ୍ରୋସପେକ୍ଟସ୍ | |
| RHP ଡ୍ରାଫ୍ଟ ପ୍ରୋସପେକ୍ଟସ୍ | - |
IPO ସ୍ନାପସଟ୍ ଏବଂ ନିବେଶକ ଟେକ୍ ଆୱେ
ଏହାର ପ୍ରାଇସ୍ ବ୍ୟାଣ୍ଡର ଉପର ମୁଣ୍ଡରେ, Avience Biomedicals ର ମୂଲ୍ୟ ସେୟାର ପିଛା ₹208 ଅଟେ। 600 ସେୟାରର ସର୍ବନିମ୍ନ ଲଟ୍ ଆକାର ସହିତ, ଗୋଟିଏ ଲଟ୍ ପାଇଁ ଆବେଦନ କରୁଥିବା ଜଣେ ଖୁଚୁରା ନିବେଶକଙ୍କୁ ଏହି SME ଇସ୍ୟୁରେ ଅଂଶଗ୍ରହଣ କରିବା ପାଇଁ ପ୍ରାୟ ₹2,49,600 ଆବଶ୍ୟକ ହେବ।
Avience Biomedicals ପାଇଁ ସର୍ବଶେଷ ରେକର୍ଡ ହୋଇଥିବା ଗ୍ରେ ମାର୍କେଟ ପ୍ରିମିୟମ୍ ₹187.2 ଅଟେ, ଯାହା ଇସ୍ୟୁ ମୂଲ୍ୟ ଉପରେ ପ୍ରାୟ 90.00% ଲାଭ ସୂଚିତ କରେ ଯଦି ଏହା ଲିଷ୍ଟିଂ ପର୍ଯ୍ୟନ୍ତ ରହିଥାଏ । GMP ଏକ ଗ୍ୟାରେଣ୍ଟିଯୁକ୍ତ ଫଳାଫଳ ପରିବର୍ତ୍ତେ ଅନୌପଚାରିକ ଧୂସର-ବଜାର ଭାବନାକୁ ପ୍ରତିଫଳିତ କରେ, ଏବଂ ଲିଷ୍ଟିଂ ଦିନ ପର୍ଯ୍ୟନ୍ତ ଯେକୌଣସି ସମୟରେ ପରିବର୍ତ୍ତନ ହୋଇପାରେ ।
ସର୍ବଶେଷ ଅଦ୍ୟତନ ଅନୁସାରେ, Avience Biomedicals ର IPO ମୋଟାମୋଟି ଭାବେ 43.79x ସବସ୍କ୍ରାଇବ୍ ହୋଇଛି, ଯେଉଁଥିରେ ବର୍ଗ ଅନୁଯାୟୀ Retail 58.97x, QIB 0.03x ରହିଛି ।
ବିଏସଇ / ଏନଏସଇର ଉତ୍ସର୍ଗୀକୃତ ଏସଏମଇ ପ୍ଲାଟଫର୍ମରେ ଏସଏମଇ ଆଇପିଓ ତାଲିକାଭୁକ୍ତ । ସେମାନେ ସାଧାରଣତଃ ଛୋଟ ଇସ୍ୟୁ ଆକାର ଏବଂ ମେନବୋର୍ଡ ଇସ୍ୟୁ ଅପେକ୍ଷା ଅଧିକ ପ୍ରତି-ଲଟ୍ ବିନିଯୋଗ ଅନ୍ତର୍ଭୁକ୍ତ କରନ୍ତି, ତୁଳନାତ୍ମକ ଭାବରେ କମ୍ ଅନୁଷ୍ଠାନିକ ଅଂଶଗ୍ରହଣ ସହିତ ।
IPO ରୋଡମ୍ୟାପ୍ ଏକ ନଜରରେ
ଦୈନିକ GMP ସ୍ଥିତି
| ତାରିଖ | GMP | ପରିବର୍ତ୍ତନ କରନ୍ତୁ | ଲାଭ |
|---|---|---|---|
| 23 Jun 2026 | ₹70.00 | - | 33.65% |
| 22 Jun 2026 | ₹70.00 | -₹15.00 | 33.65% |
| 19 Jun 2026 | ₹85.00 | +₹10.00 | 40.87% |
| 18 Jun 2026 | ₹75.00 | - | 36.06% |
ଆପ୍ଲିକେସନ୍ ଆକାର ବ୍ରେକଡାଉନ୍
| ବର୍ଗ | ଅନେକ | ସେୟାର | ପରିମାଣ |
|---|---|---|---|
| ଖୁଚୁରା ସର୍ବନିମ୍ନ | 2 ଲଟ୍ | 1,200 | ₹2,49,600 |
| ସର୍ବାଧିକ ଖୁଚୁରା | 2 ଲଟ୍ | 1,200 | ₹2,49,600 |
| S-HNI ସର୍ବନିମ୍ନ | 3 ଲଟ୍ | 1,800 | ₹3,74,400 |
| S-HNI ସର୍ବାଧିକ | 8 ଲଟ୍ | 4,800 | ₹9,98,400 |
| ବି-ଏଚ୍ ଏନ୍ ଆଇ ସର୍ବନିମ୍ନ | 9 ଲଟ୍ | 5,400 | ₹11,23,200 |
ଜାରି କରିବାର ଉଦ୍ଦେଶ୍ୟ ଏବଂ ସରକାରୀ ଦସ୍ତାବିଜ
Avience Biomedicals IPO Reservation
The Avience Biomedicals IPO allocation structure is divided among different investor categories such as QIB, NII, and retail investors. This structured distribution ensures balanced participation from institutional and individual investors during the subscription phase.
A significant portion of shares is allocated to retail investors, encouraging broader public participation, while institutional segments help provide stability and demand visibility for the issue.
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | 4,09,800 Shares | 28.19% |
| QIB (Ex. Anchor) | 2,73,600 Shares | 18.82% |
| NII Shares Offered | 2,07,000 Shares | 14.24% |
| Retail Shares Offered | 4,81,200 Shares | 33.10% |
Avience Biomedicals IPO Anchor Investors
The anchor investor segment of Avience Biomedicals IPO plays a key role in building early confidence for the issue. These investors participate before the public subscription window opens, helping establish initial demand visibility and pricing stability.
Lock-in requirements ensure that a portion of the anchor allocation remains invested for a defined period after listing, supporting market stability in the early trading phase.
| Particular | Details |
|---|---|
| Anchor Bidding Date | June 17, 2026 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| Lock-in (50% shares - 30 Days) | 2026 |
| Lock-in (50% shares - 90 Days) | 2026 |
Avience Biomedicals IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 18 Jun 2026 |
| IPO Close Date | 22 Jun 2026 |
| Basis of Allotment | 23 Jun 2026 |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 25 Jun 2026 |
Note: The timeline for Avience Biomedicals IPO is tentative and subject to change.
Avience Biomedicals IPO Promoters and Holding Pattern
The promoter group of Avience Biomedicals consists of experienced individuals who are actively involved in managing the company’s operations and strategic growth. Their continued presence ensures stability in leadership even after the public issue.
Although the IPO introduces public shareholders, the promoters will retain a significant stake in the company post listing, ensuring strong control and long-term commitment to business expansion.
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 40,31,256 | 87.89% |
| Promoter Holding Post Issue | 54,85,056 | 64.59% |
Avience Biomedicals Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Avience Biomedicals - About IPO
Avience Biomedicals Limited, founded in June 2024, is a prominent manufacturer, supplier, and exporter of molecular diagnostic products, testing solutions, and laboratory equipment. The firm specializes in molecular biotechnology, genomics, and in vitro diagnostics (IVD). Avience Biomedicals Limited enhanced its product range from IVD rapid test kits to an extensive line of medical devices, including biochemistry, hematology, and serology products.
Its product range includes Rapid Test Kits, Biochemistry Analyzers and Reagents, Molecular Diagnostics, Hematology Analyzers, and Medical Devices. The company’s products are distributed to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide and overseas as well. Along with manufacturing, the firm also serves as a distributor and trader of medical equipment. Moreover, its manufacturing facility is located in Noida, Uttar Pradesh.
Avience Biomedicals Company Financials
To Be Updated Soon
Avience Biomedicals Company Valuation – FY2026
To Be Updated Soon
Avience Biomedicals IPO Peer Group Comparison
To Be Updated Soon
IPO Lead Managers aka Merchant Bankers
- Fintellectual Corporate Advisors Pvt. Ltd.
ସମାନ IPOଗୁଡିକ ସହ Avience Biomedicals IPO ତୁଳନା କରନ୍ତୁ
Avience Biomedicals IPO ବାରମ୍ବାର ପଚରାଯାଉଥିବା ପ୍ରଶ୍ନ
Comments
Share a useful question or insight about Avience Biomedicals.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...